Skip to content

CorMedix CRMD Effective Income Tax Rate Reconciliation Transaction Cost

Effective Income Tax Rate Reconciliation Transaction Cost at other companies

ATN International logo
ATN InternationalATNI
$14K-58.2%
Vertex, Inc. logo
Vertex, Inc.VERX
0.1%-18.6pp
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$229.75K
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
-4.2%-0.9pp
Rumble, Inc. logo
Rumble, Inc.RUM
-2.8%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$229.75K

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept crmd:EffectiveIncomeTaxRateReconciliationTransactionCost.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's effective income tax rate reconciliation transaction cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's effective income tax rate reconciliation transaction cost?
CorMedix (CRMD) reported effective income tax rate reconciliation transaction cost of $530.5K in Q4 2025.
What does effective income tax rate reconciliation transaction cost mean?
This metric quantifies the absolute dollar impact of transaction-related costs, such as those incurred during mergers or acquisitions, on the company's income tax provision. It highlights how non-recurring deal-related expenses influence the overall tax burden. Investors use this to isolate the tax effects of corporate development activities from core operational tax performance.